IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy.
Yang C, Li S, Chen D, Liu D, Yang Y, Guo H, Sun N, Bai X, Li G, Zhang R, Wang T, Zhang L, Peng L, Liu S, Zhang W, Zhao G, Tu X, Tian W.
Yang C, et al. Among authors: li g.
Heliyon. 2024 Oct 26;10(21):e39858. doi: 10.1016/j.heliyon.2024.e39858. eCollection 2024 Nov 15.
Heliyon. 2024.
PMID: 39553551
Free PMC article.